Nvidias Blockbuster Quarter Reveals 200 Billion Opportunity and Edge Computing Shift as China Market Conceded Bitcoin Approaches 75K as Golden Cross Formation Captures Trader Attention Zcash Falls 9 Berkshire Hathaway Revamps Portfolio 26 Billion Delta Stake and Major Alphabet Increase Markets Brace for Trio of Economic Releases GDP Revision PCE Inflation and Oil Inventories on May 28 Mistral AI Explores Custom Chip Development to Strengthen AI Infrastructure Bayer CropScience Q4 Net Profit Rises 13 to 162 Crore on Revenue Growth INFQ Q1 2026 Earnings Loss Per Share Widens Stock Surges on No Estimate Comparison KNDI Q2 2024 Earnings Modest Profit Amid Limited Disclosure EMBJ Q1 2026 Earnings EPS Falls Short of Estimates as Shares Edge Higher YPF Q4 2025 Earnings Massive Reported Loss Despite Positive Stock Movement DHCNI Q1 2026 Earnings EPS Miss Amid Challenging Operating Environment Crown Crafts Inc CRWS Q1 2026 Earnings Reports EPS of 014 as Stock Gains Sensient Technologies SXT Shows Resilience with 130 Gain Eyes Resistance at 12430 BrightSpring Health Services BTSGU Holds Steady Consolidation Near 194 Sets Stage for Potential Breakout Twenty One Capital XXI Drops 42 Support Level in Focus Cosmos Health COSM Edges Higher Navigating Key Support and Resistance Oculis Holding OCS Edges Higher as Bulls Defend Key Support Trump Seeks Independence in Next Fed Chair Amid History of Rate Cut Pressure Core Inflation Rises to 32 in March as FirstQuarter Growth Slows Oil Surge Challenges Fed Humana Eyes MultiYear Margin and Returns Recovery Signaling Potential Strategic Turnaround Signos Raises 20M in Funding Partners with Dexcom to Expand AIPowered Weight Loss Platform Pixel Launch and Google Assistant AI Privacy Concerns May Reshape Consumer Trust IntermediateTerm Technical Outlook Turns Bullish What Investors Should Know Singtel Shares Slide 64 on Weak Singapore Business Performance Telco Reaffirms Optus Commitment Cadeler AS CDLR Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Inches Higher Vor Biopharma Surges 546 as Buyers Defend Key Support Level VOR